BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28844940)

  • 1. Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin.
    Albibas AA; Rose-Zerilli MJJ; Lai C; Pengelly RJ; Lockett GA; Theaker J; Ennis S; Holloway JW; Healy E
    J Invest Dermatol; 2018 Jan; 138(1):189-198. PubMed ID: 28844940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solar (actinic) keratosis is squamous cell carcinoma.
    Ackerman AB; Mones JM
    Br J Dermatol; 2006 Jul; 155(1):9-22. PubMed ID: 16792746
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein.
    Castrén K; Vähäkangas K; Heikkinen E; Ranki A
    Int J Cancer; 1998 Aug; 77(5):674-8. PubMed ID: 9688297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family with MSH2 mutation presenting with keratoacanthoma and precancerous skin lesions.
    Hatta N; Takata A; Ishizawa S; Niida Y
    J Dermatol; 2015 Nov; 42(11):1087-90. PubMed ID: 26077460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
    Ren ZP; Pontén F; Nistér M; Pontén J
    Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beyond actinic keratoses: Field cancerization of the skin].
    Reygagne P; Rostain G
    Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin.
    Campbell C; Quinn AG; Ro YS; Angus B; Rees JL
    J Invest Dermatol; 1993 Jun; 100(6):746-8. PubMed ID: 8496613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics of melanoma and nonmelanoma skin cancer.
    Carless MA; Griffiths LR
    Adv Exp Med Biol; 2014; 810():160-81. PubMed ID: 25207365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.
    Ren ZP; Ahmadian A; Pontén F; Nistér M; Berg C; Lundeberg J; Uhlén M; Pontén J
    Am J Pathol; 1997 May; 150(5):1791-803. PubMed ID: 9137102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bowen type degeneration on a zoniform porokeratosis of Mibelli].
    Beylot C; Bioulac P; Conte M; Coindre JM; Raynal F
    Ann Dermatol Venereol; 1977; 104(8-9):579-82. PubMed ID: 931314
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
    Onodera H; Nakamura S; Sugai T
    Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
    Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
    Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
    Takata M; Rehman I; Rees JL
    Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
    Ichikawa E; Watanabe S; Otsuka F
    Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.